Interleukin-13 Antagonist
- Name
- Interleukin-13 Antagonist
- Accession Number
- DBCAT005652
- Description
Not Available
- Drugs
Drug Drug Description Tralokinumab A monoclonal antibody directed against interleukin-13 which is used in the treatment of moderate-to-severe atopic dermatitis in patients requiring systemic therapy. - Drugs & Drug Targets
Drug Target Type Tralokinumab Interleukin-13 target